Leading Companies Fueling Growth and Innovation in the Vaccine Delivery Devices Market

An Overview of the Vaccine Delivery Devices Market Outlook
The vaccine delivery devices sector is positioned for significant expansion in the coming years. With rising technological advancements and increased focus on efficient vaccine administration, this market is expected to witness remarkable progress. Let's explore the market size predictions, key players, emerging trends, and segmentation details that define this evolving industry.

Projected Growth and Market Size of the Vaccine Delivery Devices Market
The vaccine delivery devices market is anticipated to reach a valuation of $10.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0%. This upward trajectory is driven by the development of next-generation vaccines, increased adoption of self-administration tools, expansion of pandemic preparedness initiatives, and greater investments aimed at improving vaccine access. Additionally, emphasis on dose precision and patient compliance plays a crucial role in fueling this growth. Key trends shaping the forecast period include the rising use of needle-free injection technology, growing demand for microneedle patch systems, alternative vaccine delivery methods, expanded mass immunization programs, and heightened attention to patient comfort and safety during vaccination.

Download a free sample of the vaccine delivery devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15952&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Top Companies Driving the Vaccine Delivery Devices Industry
The vaccine delivery devices market features several prominent players that influence its development and innovation. Leading companies include Johnson & Johnson, Sanofi S.A., 3M Company, GlaxoSmithKline plc, Becton dic*kinson and Company, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, SHL Medical AG, Portal Instruments Inc., ApiJect Systems Corp., Credence MedSystems Inc., and Zosano Pharma Corporation.

Expansion Efforts by Key Industry Players in 2024
In March 2024, Sharps Technology Inc., a US-based medical device manufacturer, joined forces with Roncadelle Operations to enhance high-precision syringe production and boost global supply capacity for advanced vaccine delivery solutions. This collaboration aims to support the development of next-generation prefillable syringe systems and custom auto-injector components, while also expanding manufacturing operations within the United States. Roncadelle Operations s.r.l., an Italy-based company, specializes in delivering vaccine devices and injectable drug delivery technologies.

View the full vaccine delivery devices market report:
https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Emerging Trends in Vaccine Delivery Solutions
Leading companies in this market are focusing on innovative vaccine administration methods to improve efficiency and minimize wastage. One notable advancement is the development of intradermal delivery systems designed to deposit vaccines directly into the skin's dermal layer. This technique takes advantage of the high concentration of immune cells in that area, resulting in stronger immune responses with lower vaccine doses.

An Example of Intradermal Delivery Innovation
For instance, in July 2025, Japan's Terumo Corporation introduced the Immucise Intradermal Injection System, a vertical-puncture device featuring a 33-gauge needle for precise vaccine delivery into the dermis. This technology ensures consistent formation of the wheal with minimal leakage and offers improved accuracy compared to the traditional Mantoux method. The Immucise system reduces required vaccine doses, supports stronger immunogenicity, and streamlines vaccination processes by reducing operational challenges and optimizing resource use.

Detailed Segmentation of the Global Vaccine Delivery Devices Market
This report breaks down the vaccine delivery devices market into specific categories based on device type, route of administration, and end-user groups.

Segmentation by Type of Device includes:
- Needle Free Injection Systems
- Oral Delivery Systems
- Nasal Delivery Systems
- Jet Injectors
- Microneedle Patches and Microinjectors

Segmentation by Route of Administration covers:
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- Other Vaccinations

End User segments comprise:
- Hospitals
- Clinics
- Other End Users

Further subcategories provide deeper insight, including:
Needle Free Injection Systems subdivided into Spring-Based Injectors, Gas-Driven Injectors, and Hybrid Injectors; Oral Delivery Systems broken down into Oral Tablets and Capsules, Oral Sprays, and Oral Solutions; Nasal Delivery Systems divided into Nasal Sprays, Nasal Drops, and Nasal Powder Systems; Jet Injectors classified as Pneumatic Jet Injectors and Electromechanical Jet Injectors; and Microneedle Patches and Microinjectors segmented into Dissolvable Microneedles, Solid Microneedles, and Microinjector Devices.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.